NCT02926573View on ClinicalTrials.gov

Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

June 24, 2016

Primary Completion Date

June 21, 2017

Study Completion Date

June 21, 2017

Conditions
Head and Neck CancerAcute PainPostoperative Pain
Interventions
DRUG

Gabapentin

DRUG

Placebo

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02926573 - Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients | Biotech Hunter | Biotech Hunter